Senior Director, Market Access, International

The role

You will lead pricing and reimbursement strategies to secure patient access to products across multiple international markets. You will shape value narratives and oversee dossiers, negotiations, and cost coverage approaches.

What you will do

• Represent the payer perspective within cross-functional, cross-regional commercialization teams.
• Collaborate with HEOR, clusters' leadership, Marketing, and Clinical Development counterparts.
• Lead early payer engagement with key HTA/payer bodies to inform evidence generation and reimbursement dossiers.
• Interact with internal and external experts in pricing, health economics, patient advocacy, and government policy makers.
• Provide hands-on support and train local access teams on negotiation strategy.
• Ensure HTA and reimbursement submissions align with Global and International strategy.

Required qualifications

• Extensive experience leading HTA submissions and pricing negotiations across multiple international markets.
• Strong knowledge of international healthcare systems, pricing and reimbursement frameworks, and regulatory environments.
• Experience generating and leveraging data for HTA submissions and pricing negotiations.
• Strong external network of agencies and stakeholders.
• Comfortable presenting at senior levels and engaging with external thought leaders globally.
• Proven experience managing complex, cross-functional and multicultural teams.
• Knowledge of product commercialization processes with a hands-on, solution-oriented mindset.

Nice to have

• Experience in rare diseases and orphan conditions

Benefits

• Market leading compensation
• Hybrid work model
• Career development through regular feedback, continuous education and professional development programs
• Financial rewards for strong performance
• Peer-to-peer recognition
• Growth opportunities

About the company

BridgeBio is a global biotechnology company that uses a model of pooling projects and early-stage research to develop medicines for rare diseases. The company has a Global Headquarters in San Francisco and an International HQ in Zug, Switzerland.